nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethadione—CYP2C8—Tazarotene—psoriasis	0.12	0.162	CbGbCtD
Trimethadione—CYP2C8—Cholecalciferol—psoriasis	0.0512	0.0691	CbGbCtD
Trimethadione—CYP2C8—Mycophenolate mofetil—psoriasis	0.0444	0.0599	CbGbCtD
Trimethadione—CYP2C19—Cholecalciferol—psoriasis	0.043	0.0579	CbGbCtD
Trimethadione—CYP3A4—Calcitriol—psoriasis	0.0403	0.0544	CbGbCtD
Trimethadione—CYP2C9—Cholecalciferol—psoriasis	0.0357	0.0482	CbGbCtD
Trimethadione—CYP2C8—Hydrocortisone—psoriasis	0.0357	0.0481	CbGbCtD
Trimethadione—CYP2C8—Cyclosporine—psoriasis	0.0337	0.0454	CbGbCtD
Trimethadione—CYP3A4—Methoxsalen—psoriasis	0.0314	0.0423	CbGbCtD
Trimethadione—CYP2C19—Prednisone—psoriasis	0.0298	0.0402	CbGbCtD
Trimethadione—CYP2E1—Dexamethasone—psoriasis	0.0297	0.04	CbGbCtD
Trimethadione—CYP2C19—Cyclosporine—psoriasis	0.0282	0.0381	CbGbCtD
Trimethadione—CYP2C9—Cyclosporine—psoriasis	0.0235	0.0317	CbGbCtD
Trimethadione—CYP2C8—Dexamethasone—psoriasis	0.0222	0.0299	CbGbCtD
Trimethadione—CYP3A4—Cholecalciferol—psoriasis	0.0208	0.028	CbGbCtD
Trimethadione—CYP2C19—Dexamethasone—psoriasis	0.0186	0.0251	CbGbCtD
Trimethadione—CYP3A4—Mycophenolate mofetil—psoriasis	0.018	0.0243	CbGbCtD
Trimethadione—CYP3A4—Triamcinolone—psoriasis	0.018	0.0243	CbGbCtD
Trimethadione—CYP2C9—Dexamethasone—psoriasis	0.0155	0.0208	CbGbCtD
Trimethadione—CYP3A4—Betamethasone—psoriasis	0.0155	0.0208	CbGbCtD
Trimethadione—CYP3A4—Prednisolone—psoriasis	0.0153	0.0206	CbGbCtD
Trimethadione—CYP3A4—Hydrocortisone—psoriasis	0.0145	0.0195	CbGbCtD
Trimethadione—CYP3A4—Prednisone—psoriasis	0.0144	0.0194	CbGbCtD
Trimethadione—CYP3A4—Cyclosporine—psoriasis	0.0137	0.0184	CbGbCtD
Trimethadione—CYP3A4—Dexamethasone—psoriasis	0.00899	0.0121	CbGbCtD
Trimethadione—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00151	0.0885	CbGpPWpGaD
Trimethadione—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.0013	0.0765	CbGpPWpGaD
Trimethadione—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00116	0.0683	CbGpPWpGaD
Trimethadione—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00106	0.0623	CbGpPWpGaD
Trimethadione—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.000934	0.0549	CbGpPWpGaD
Trimethadione—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000807	0.0474	CbGpPWpGaD
Trimethadione—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00072	0.0423	CbGpPWpGaD
Trimethadione—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000657	0.0386	CbGpPWpGaD
Trimethadione—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000433	0.0255	CbGpPWpGaD
Trimethadione—Rash—Calcitriol—psoriasis	0.000407	0.00169	CcSEcCtD
Trimethadione—Dermatitis—Calcitriol—psoriasis	0.000407	0.00169	CcSEcCtD
Trimethadione—Pruritus—Acitretin—psoriasis	0.000406	0.00169	CcSEcCtD
Trimethadione—Pruritus—Fluocinolone Acetonide—psoriasis	0.000405	0.00168	CcSEcCtD
Trimethadione—Headache—Calcitriol—psoriasis	0.000404	0.00168	CcSEcCtD
Trimethadione—Lymphadenopathy—Methotrexate—psoriasis	0.000402	0.00167	CcSEcCtD
Trimethadione—Somnolence—Hydroxyurea—psoriasis	0.000401	0.00166	CcSEcCtD
Trimethadione—Haemoglobin—Prednisolone—psoriasis	0.000393	0.00163	CcSEcCtD
Trimethadione—Irritability—Prednisone—psoriasis	0.000392	0.00163	CcSEcCtD
Trimethadione—Decreased appetite—Hydroxyurea—psoriasis	0.000392	0.00163	CcSEcCtD
Trimethadione—Haemorrhage—Prednisolone—psoriasis	0.000391	0.00162	CcSEcCtD
Trimethadione—Discomfort—Mycophenolic acid—psoriasis	0.000389	0.00161	CcSEcCtD
Trimethadione—Fatigue—Hydroxyurea—psoriasis	0.000389	0.00161	CcSEcCtD
Trimethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000388	0.0228	CbGpPWpGaD
Trimethadione—Haemoglobin—Hydrocortisone—psoriasis	0.000384	0.00159	CcSEcCtD
Trimethadione—Nausea—Calcitriol—psoriasis	0.000383	0.00159	CcSEcCtD
Trimethadione—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000383	0.0225	CbGpPWpGaD
Trimethadione—Haemorrhage—Hydrocortisone—psoriasis	0.000382	0.00159	CcSEcCtD
Trimethadione—Alopecia—Cyclosporine—psoriasis	0.00038	0.00158	CcSEcCtD
Trimethadione—Epistaxis—Triamcinolone—psoriasis	0.000378	0.00157	CcSEcCtD
Trimethadione—Feeling abnormal—Hydroxyurea—psoriasis	0.000371	0.00154	CcSEcCtD
Trimethadione—Alopecia—Mycophenolate mofetil—psoriasis	0.000371	0.00154	CcSEcCtD
Trimethadione—Thrombocytopenia—Mycophenolic acid—psoriasis	0.00037	0.00153	CcSEcCtD
Trimethadione—Weight decreased—Dexamethasone—psoriasis	0.000369	0.00153	CcSEcCtD
Trimethadione—Weight decreased—Betamethasone—psoriasis	0.000369	0.00153	CcSEcCtD
Trimethadione—Vomiting—Acitretin—psoriasis	0.000365	0.00151	CcSEcCtD
Trimethadione—Vomiting—Fluocinolone Acetonide—psoriasis	0.000364	0.00151	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Methotrexate—psoriasis	0.000364	0.00151	CcSEcCtD
Trimethadione—Rash—Acitretin—psoriasis	0.000362	0.0015	CcSEcCtD
Trimethadione—Dermatitis—Acitretin—psoriasis	0.000362	0.0015	CcSEcCtD
Trimethadione—Haemoglobin—Triamcinolone—psoriasis	0.000362	0.0015	CcSEcCtD
Trimethadione—Rash—Fluocinolone Acetonide—psoriasis	0.000361	0.0015	CcSEcCtD
Trimethadione—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000361	0.0015	CcSEcCtD
Trimethadione—Anorexia—Mycophenolic acid—psoriasis	0.00036	0.00149	CcSEcCtD
Trimethadione—Haemorrhage—Triamcinolone—psoriasis	0.00036	0.00149	CcSEcCtD
Trimethadione—Headache—Acitretin—psoriasis	0.00036	0.00149	CcSEcCtD
Trimethadione—Headache—Fluocinolone Acetonide—psoriasis	0.000359	0.00149	CcSEcCtD
Trimethadione—Ill-defined disorder—Cyclosporine—psoriasis	0.000347	0.00144	CcSEcCtD
Trimethadione—Insomnia—Mycophenolic acid—psoriasis	0.000341	0.00142	CcSEcCtD
Trimethadione—Nausea—Acitretin—psoriasis	0.000341	0.00142	CcSEcCtD
Trimethadione—Nausea—Fluocinolone Acetonide—psoriasis	0.00034	0.00141	CcSEcCtD
Trimethadione—Paraesthesia—Mycophenolic acid—psoriasis	0.000339	0.00141	CcSEcCtD
Trimethadione—Ill-defined disorder—Mycophenolate mofetil—psoriasis	0.000339	0.00141	CcSEcCtD
Trimethadione—Malaise—Cyclosporine—psoriasis	0.000337	0.0014	CcSEcCtD
Trimethadione—Vertigo—Cyclosporine—psoriasis	0.000336	0.0014	CcSEcCtD
Trimethadione—Somnolence—Mycophenolic acid—psoriasis	0.000336	0.00139	CcSEcCtD
Trimethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000335	0.0197	CbGpPWpGaD
Trimethadione—Leukopenia—Cyclosporine—psoriasis	0.000335	0.00139	CcSEcCtD
Trimethadione—Neutropenia—Prednisone—psoriasis	0.000332	0.00138	CcSEcCtD
Trimethadione—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000331	0.0194	CbGpPWpGaD
Trimethadione—Malaise—Mycophenolate mofetil—psoriasis	0.000329	0.00137	CcSEcCtD
Trimethadione—Decreased appetite—Mycophenolic acid—psoriasis	0.000328	0.00136	CcSEcCtD
Trimethadione—Haemoglobin—Dexamethasone—psoriasis	0.000328	0.00136	CcSEcCtD
Trimethadione—Haemoglobin—Betamethasone—psoriasis	0.000328	0.00136	CcSEcCtD
Trimethadione—Vertigo—Mycophenolate mofetil—psoriasis	0.000328	0.00136	CcSEcCtD
Trimethadione—Irritability—Methotrexate—psoriasis	0.000328	0.00136	CcSEcCtD
Trimethadione—Leukopenia—Mycophenolate mofetil—psoriasis	0.000327	0.00136	CcSEcCtD
Trimethadione—Haemorrhage—Dexamethasone—psoriasis	0.000326	0.00135	CcSEcCtD
Trimethadione—Haemorrhage—Betamethasone—psoriasis	0.000326	0.00135	CcSEcCtD
Trimethadione—Fatigue—Mycophenolic acid—psoriasis	0.000325	0.00135	CcSEcCtD
Trimethadione—Asthenia—Hydroxyurea—psoriasis	0.000323	0.00134	CcSEcCtD
Trimethadione—Weight decreased—Prednisone—psoriasis	0.000321	0.00133	CcSEcCtD
Trimethadione—Ill-defined disorder—Prednisolone—psoriasis	0.000316	0.00131	CcSEcCtD
Trimethadione—Discomfort—Cyclosporine—psoriasis	0.000315	0.00131	CcSEcCtD
Trimethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000314	0.0185	CbGpPWpGaD
Trimethadione—Feeling abnormal—Mycophenolic acid—psoriasis	0.000311	0.00129	CcSEcCtD
Trimethadione—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000309	0.00128	CcSEcCtD
Trimethadione—Ill-defined disorder—Hydrocortisone—psoriasis	0.000309	0.00128	CcSEcCtD
Trimethadione—Malaise—Prednisolone—psoriasis	0.000307	0.00127	CcSEcCtD
Trimethadione—Discomfort—Mycophenolate mofetil—psoriasis	0.000307	0.00127	CcSEcCtD
Trimethadione—Vertigo—Prednisolone—psoriasis	0.000306	0.00127	CcSEcCtD
Trimethadione—Malaise—Hydrocortisone—psoriasis	0.0003	0.00124	CcSEcCtD
Trimethadione—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000299	0.0176	CbGpPWpGaD
Trimethadione—Thrombocytopenia—Cyclosporine—psoriasis	0.000299	0.00124	CcSEcCtD
Trimethadione—Vertigo—Hydrocortisone—psoriasis	0.000299	0.00124	CcSEcCtD
Trimethadione—Abdominal pain—Mycophenolic acid—psoriasis	0.000298	0.00124	CcSEcCtD
Trimethadione—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000295	0.0173	CbGpPWpGaD
Trimethadione—Eosinophilia—Methotrexate—psoriasis	0.000294	0.00122	CcSEcCtD
Trimethadione—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000292	0.00121	CcSEcCtD
Trimethadione—Anorexia—Cyclosporine—psoriasis	0.000291	0.00121	CcSEcCtD
Trimethadione—Ill-defined disorder—Triamcinolone—psoriasis	0.000291	0.00121	CcSEcCtD
Trimethadione—Alopecia—Dexamethasone—psoriasis	0.000288	0.0012	CcSEcCtD
Trimethadione—Alopecia—Betamethasone—psoriasis	0.000288	0.0012	CcSEcCtD
Trimethadione—Vomiting—Hydroxyurea—psoriasis	0.000287	0.00119	CcSEcCtD
Trimethadione—Discomfort—Prednisolone—psoriasis	0.000286	0.00119	CcSEcCtD
Trimethadione—Haemoglobin—Prednisone—psoriasis	0.000286	0.00119	CcSEcCtD
Trimethadione—Haemorrhage—Prednisone—psoriasis	0.000284	0.00118	CcSEcCtD
Trimethadione—Rash—Hydroxyurea—psoriasis	0.000284	0.00118	CcSEcCtD
Trimethadione—Anorexia—Mycophenolate mofetil—psoriasis	0.000284	0.00118	CcSEcCtD
Trimethadione—Dermatitis—Hydroxyurea—psoriasis	0.000284	0.00118	CcSEcCtD
Trimethadione—Malaise—Triamcinolone—psoriasis	0.000282	0.00117	CcSEcCtD
Trimethadione—Headache—Hydroxyurea—psoriasis	0.000282	0.00117	CcSEcCtD
Trimethadione—Pancytopenia—Methotrexate—psoriasis	0.000282	0.00117	CcSEcCtD
Trimethadione—Vertigo—Triamcinolone—psoriasis	0.000281	0.00117	CcSEcCtD
Trimethadione—Discomfort—Hydrocortisone—psoriasis	0.00028	0.00116	CcSEcCtD
Trimethadione—Neutropenia—Methotrexate—psoriasis	0.000278	0.00115	CcSEcCtD
Trimethadione—Insomnia—Cyclosporine—psoriasis	0.000276	0.00115	CcSEcCtD
Trimethadione—Paraesthesia—Cyclosporine—psoriasis	0.000274	0.00114	CcSEcCtD
Trimethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000273	0.016	CbGpPWpGaD
Trimethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000272	0.016	CbGpPWpGaD
Trimethadione—Somnolence—Cyclosporine—psoriasis	0.000272	0.00113	CcSEcCtD
Trimethadione—Asthenia—Mycophenolic acid—psoriasis	0.000271	0.00112	CcSEcCtD
Trimethadione—Insomnia—Mycophenolate mofetil—psoriasis	0.000269	0.00112	CcSEcCtD
Trimethadione—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000269	0.0158	CbGpPWpGaD
Trimethadione—Nausea—Hydroxyurea—psoriasis	0.000268	0.00111	CcSEcCtD
Trimethadione—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000268	0.00111	CcSEcCtD
Trimethadione—Pruritus—Mycophenolic acid—psoriasis	0.000267	0.00111	CcSEcCtD
Trimethadione—Decreased appetite—Cyclosporine—psoriasis	0.000265	0.0011	CcSEcCtD
Trimethadione—Somnolence—Mycophenolate mofetil—psoriasis	0.000265	0.0011	CcSEcCtD
Trimethadione—Drowsiness—Methotrexate—psoriasis	0.000265	0.0011	CcSEcCtD
Trimethadione—Ill-defined disorder—Dexamethasone—psoriasis	0.000264	0.00109	CcSEcCtD
Trimethadione—Ill-defined disorder—Betamethasone—psoriasis	0.000264	0.00109	CcSEcCtD
Trimethadione—Discomfort—Triamcinolone—psoriasis	0.000263	0.00109	CcSEcCtD
Trimethadione—Fatigue—Cyclosporine—psoriasis	0.000263	0.00109	CcSEcCtD
Trimethadione—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000259	0.00107	CcSEcCtD
Trimethadione—Anorexia—Hydrocortisone—psoriasis	0.000259	0.00107	CcSEcCtD
Trimethadione—Malaise—Dexamethasone—psoriasis	0.000256	0.00106	CcSEcCtD
Trimethadione—Malaise—Betamethasone—psoriasis	0.000256	0.00106	CcSEcCtD
Trimethadione—Vertigo—Betamethasone—psoriasis	0.000255	0.00106	CcSEcCtD
Trimethadione—Vertigo—Dexamethasone—psoriasis	0.000255	0.00106	CcSEcCtD
Trimethadione—Feeling abnormal—Cyclosporine—psoriasis	0.000252	0.00104	CcSEcCtD
Trimethadione—Insomnia—Prednisolone—psoriasis	0.000251	0.00104	CcSEcCtD
Trimethadione—Alopecia—Prednisone—psoriasis	0.000251	0.00104	CcSEcCtD
Trimethadione—Gastrointestinal pain—Cyclosporine—psoriasis	0.00025	0.00104	CcSEcCtD
Trimethadione—Epistaxis—Methotrexate—psoriasis	0.00025	0.00104	CcSEcCtD
Trimethadione—Paraesthesia—Prednisolone—psoriasis	0.00025	0.00104	CcSEcCtD
Trimethadione—Agranulocytosis—Methotrexate—psoriasis	0.000247	0.00102	CcSEcCtD
Trimethadione—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000246	0.00102	CcSEcCtD
Trimethadione—Insomnia—Hydrocortisone—psoriasis	0.000245	0.00102	CcSEcCtD
Trimethadione—Paraesthesia—Hydrocortisone—psoriasis	0.000244	0.00101	CcSEcCtD
Trimethadione—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000244	0.00101	CcSEcCtD
Trimethadione—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000242	0.0143	CbGpPWpGaD
Trimethadione—Abdominal pain—Cyclosporine—psoriasis	0.000241	0.001	CcSEcCtD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.00024	0.0141	CbGpPWpGaD
Trimethadione—Vomiting—Mycophenolic acid—psoriasis	0.00024	0.000996	CcSEcCtD
Trimethadione—Discomfort—Dexamethasone—psoriasis	0.000239	0.000992	CcSEcCtD
Trimethadione—Discomfort—Betamethasone—psoriasis	0.000239	0.000992	CcSEcCtD
Trimethadione—Haemoglobin—Methotrexate—psoriasis	0.000239	0.000991	CcSEcCtD
Trimethadione—Rash—Mycophenolic acid—psoriasis	0.000238	0.000988	CcSEcCtD
Trimethadione—Dermatitis—Mycophenolic acid—psoriasis	0.000238	0.000987	CcSEcCtD
Trimethadione—Haemorrhage—Methotrexate—psoriasis	0.000238	0.000986	CcSEcCtD
Trimethadione—Hepatitis—Methotrexate—psoriasis	0.000238	0.000986	CcSEcCtD
Trimethadione—Headache—Mycophenolic acid—psoriasis	0.000237	0.000981	CcSEcCtD
Trimethadione—Decreased appetite—Hydrocortisone—psoriasis	0.000236	0.000979	CcSEcCtD
Trimethadione—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000236	0.000977	CcSEcCtD
Trimethadione—Fatigue—Hydrocortisone—psoriasis	0.000234	0.000971	CcSEcCtD
Trimethadione—Insomnia—Triamcinolone—psoriasis	0.000231	0.000959	CcSEcCtD
Trimethadione—Ill-defined disorder—Prednisone—psoriasis	0.00023	0.000953	CcSEcCtD
Trimethadione—Paraesthesia—Triamcinolone—psoriasis	0.000229	0.000952	CcSEcCtD
Trimethadione—Feeling abnormal—Prednisolone—psoriasis	0.000229	0.00095	CcSEcCtD
Trimethadione—Thrombocytopenia—Betamethasone—psoriasis	0.000227	0.000942	CcSEcCtD
Trimethadione—Thrombocytopenia—Dexamethasone—psoriasis	0.000227	0.000942	CcSEcCtD
Trimethadione—Erythema multiforme—Methotrexate—psoriasis	0.000225	0.000932	CcSEcCtD
Trimethadione—Nausea—Mycophenolic acid—psoriasis	0.000224	0.000931	CcSEcCtD
Trimethadione—Feeling abnormal—Hydrocortisone—psoriasis	0.000224	0.000928	CcSEcCtD
Trimethadione—Malaise—Prednisone—psoriasis	0.000223	0.000926	CcSEcCtD
Trimethadione—Vertigo—Prednisone—psoriasis	0.000222	0.000923	CcSEcCtD
Trimethadione—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000222	0.000921	CcSEcCtD
Trimethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000221	0.013	CbGpPWpGaD
Trimethadione—Anorexia—Betamethasone—psoriasis	0.000221	0.000917	CcSEcCtD
Trimethadione—Anorexia—Dexamethasone—psoriasis	0.000221	0.000917	CcSEcCtD
Trimethadione—Fatigue—Triamcinolone—psoriasis	0.00022	0.000914	CcSEcCtD
Trimethadione—Asthenia—Cyclosporine—psoriasis	0.000219	0.000909	CcSEcCtD
Trimethadione—Pruritus—Cyclosporine—psoriasis	0.000216	0.000897	CcSEcCtD
Trimethadione—Abdominal pain—Hydrocortisone—psoriasis	0.000215	0.00089	CcSEcCtD
Trimethadione—Asthenia—Mycophenolate mofetil—psoriasis	0.000214	0.000887	CcSEcCtD
Trimethadione—Pruritus—Mycophenolate mofetil—psoriasis	0.000211	0.000875	CcSEcCtD
Trimethadione—Feeling abnormal—Triamcinolone—psoriasis	0.000211	0.000874	CcSEcCtD
Trimethadione—Alopecia—Methotrexate—psoriasis	0.00021	0.000871	CcSEcCtD
Trimethadione—Insomnia—Betamethasone—psoriasis	0.00021	0.00087	CcSEcCtD
Trimethadione—Insomnia—Dexamethasone—psoriasis	0.00021	0.00087	CcSEcCtD
Trimethadione—Paraesthesia—Dexamethasone—psoriasis	0.000208	0.000864	CcSEcCtD
Trimethadione—Paraesthesia—Betamethasone—psoriasis	0.000208	0.000864	CcSEcCtD
Trimethadione—Discomfort—Prednisone—psoriasis	0.000208	0.000864	CcSEcCtD
Trimethadione—Decreased appetite—Dexamethasone—psoriasis	0.000202	0.000837	CcSEcCtD
Trimethadione—Decreased appetite—Betamethasone—psoriasis	0.000202	0.000837	CcSEcCtD
Trimethadione—Fatigue—Dexamethasone—psoriasis	0.0002	0.00083	CcSEcCtD
Trimethadione—Fatigue—Betamethasone—psoriasis	0.0002	0.00083	CcSEcCtD
Trimethadione—Asthenia—Hydrocortisone—psoriasis	0.000195	0.000808	CcSEcCtD
Trimethadione—Vomiting—Cyclosporine—psoriasis	0.000194	0.000806	CcSEcCtD
Trimethadione—Rash—Cyclosporine—psoriasis	0.000193	0.000799	CcSEcCtD
Trimethadione—Anorexia—Prednisone—psoriasis	0.000193	0.000799	CcSEcCtD
Trimethadione—Dermatitis—Cyclosporine—psoriasis	0.000192	0.000798	CcSEcCtD
Trimethadione—Pruritus—Hydrocortisone—psoriasis	0.000192	0.000797	CcSEcCtD
Trimethadione—Ill-defined disorder—Methotrexate—psoriasis	0.000192	0.000796	CcSEcCtD
Trimethadione—Headache—Cyclosporine—psoriasis	0.000191	0.000794	CcSEcCtD
Trimethadione—Feeling abnormal—Dexamethasone—psoriasis	0.000191	0.000793	CcSEcCtD
Trimethadione—Feeling abnormal—Betamethasone—psoriasis	0.000191	0.000793	CcSEcCtD
Trimethadione—Gastrointestinal pain—Dexamethasone—psoriasis	0.00019	0.000787	CcSEcCtD
Trimethadione—Gastrointestinal pain—Betamethasone—psoriasis	0.00019	0.000787	CcSEcCtD
Trimethadione—Vomiting—Mycophenolate mofetil—psoriasis	0.000189	0.000786	CcSEcCtD
Trimethadione—Rash—Mycophenolate mofetil—psoriasis	0.000188	0.00078	CcSEcCtD
Trimethadione—Dermatitis—Mycophenolate mofetil—psoriasis	0.000188	0.000779	CcSEcCtD
Trimethadione—Headache—Mycophenolate mofetil—psoriasis	0.000187	0.000775	CcSEcCtD
Trimethadione—Malaise—Methotrexate—psoriasis	0.000186	0.000774	CcSEcCtD
Trimethadione—Vertigo—Methotrexate—psoriasis	0.000186	0.000771	CcSEcCtD
Trimethadione—Leukopenia—Methotrexate—psoriasis	0.000185	0.000768	CcSEcCtD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—psoriasis	0.000184	0.0108	CbGpPWpGaD
Trimethadione—Asthenia—Triamcinolone—psoriasis	0.000183	0.000761	CcSEcCtD
Trimethadione—Abdominal pain—Dexamethasone—psoriasis	0.000183	0.000761	CcSEcCtD
Trimethadione—Abdominal pain—Betamethasone—psoriasis	0.000183	0.000761	CcSEcCtD
Trimethadione—Insomnia—Prednisone—psoriasis	0.000183	0.000758	CcSEcCtD
Trimethadione—Nausea—Cyclosporine—psoriasis	0.000181	0.000753	CcSEcCtD
Trimethadione—Paraesthesia—Prednisone—psoriasis	0.000181	0.000753	CcSEcCtD
Trimethadione—Pruritus—Triamcinolone—psoriasis	0.000181	0.00075	CcSEcCtD
Trimethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00018	0.0106	CbGpPWpGaD
Trimethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000178	0.0105	CbGpPWpGaD
Trimethadione—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000178	0.0104	CbGpPWpGaD
Trimethadione—Nausea—Mycophenolate mofetil—psoriasis	0.000177	0.000734	CcSEcCtD
Trimethadione—Decreased appetite—Prednisone—psoriasis	0.000176	0.000729	CcSEcCtD
Trimethadione—Rash—Prednisolone—psoriasis	0.000175	0.000727	CcSEcCtD
Trimethadione—Dermatitis—Prednisolone—psoriasis	0.000175	0.000726	CcSEcCtD
Trimethadione—Fatigue—Prednisone—psoriasis	0.000174	0.000723	CcSEcCtD
Trimethadione—Headache—Prednisolone—psoriasis	0.000174	0.000722	CcSEcCtD
Trimethadione—Discomfort—Methotrexate—psoriasis	0.000174	0.000722	CcSEcCtD
Trimethadione—Vomiting—Hydrocortisone—psoriasis	0.000173	0.000716	CcSEcCtD
Trimethadione—Rash—Hydrocortisone—psoriasis	0.000171	0.00071	CcSEcCtD
Trimethadione—Dermatitis—Hydrocortisone—psoriasis	0.000171	0.00071	CcSEcCtD
Trimethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	0.000171	0.01	CbGpPWpGaD
Trimethadione—Headache—Hydrocortisone—psoriasis	0.00017	0.000706	CcSEcCtD
Trimethadione—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000167	0.00981	CbGpPWpGaD
Trimethadione—Feeling abnormal—Prednisone—psoriasis	0.000166	0.000691	CcSEcCtD
Trimethadione—Asthenia—Betamethasone—psoriasis	0.000166	0.00069	CcSEcCtD
Trimethadione—Asthenia—Dexamethasone—psoriasis	0.000166	0.00069	CcSEcCtD
Trimethadione—Thrombocytopenia—Methotrexate—psoriasis	0.000165	0.000686	CcSEcCtD
Trimethadione—Gastrointestinal pain—Prednisone—psoriasis	0.000165	0.000685	CcSEcCtD
Trimethadione—Nausea—Prednisolone—psoriasis	0.000165	0.000685	CcSEcCtD
Trimethadione—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000165	0.00968	CbGpPWpGaD
Trimethadione—Pruritus—Dexamethasone—psoriasis	0.000164	0.000681	CcSEcCtD
Trimethadione—Pruritus—Betamethasone—psoriasis	0.000164	0.000681	CcSEcCtD
Trimethadione—Vomiting—Triamcinolone—psoriasis	0.000162	0.000674	CcSEcCtD
Trimethadione—Nausea—Hydrocortisone—psoriasis	0.000161	0.000669	CcSEcCtD
Trimethadione—Rash—Triamcinolone—psoriasis	0.000161	0.000669	CcSEcCtD
Trimethadione—Dermatitis—Triamcinolone—psoriasis	0.000161	0.000668	CcSEcCtD
Trimethadione—Anorexia—Methotrexate—psoriasis	0.000161	0.000668	CcSEcCtD
Trimethadione—Headache—Triamcinolone—psoriasis	0.00016	0.000664	CcSEcCtD
Trimethadione—Abdominal pain—Prednisone—psoriasis	0.00016	0.000662	CcSEcCtD
Trimethadione—Insomnia—Methotrexate—psoriasis	0.000153	0.000633	CcSEcCtD
Trimethadione—Nausea—Triamcinolone—psoriasis	0.000152	0.00063	CcSEcCtD
Trimethadione—Paraesthesia—Methotrexate—psoriasis	0.000152	0.000629	CcSEcCtD
Trimethadione—Somnolence—Methotrexate—psoriasis	0.00015	0.000623	CcSEcCtD
Trimethadione—Vomiting—Dexamethasone—psoriasis	0.000147	0.000612	CcSEcCtD
Trimethadione—Vomiting—Betamethasone—psoriasis	0.000147	0.000612	CcSEcCtD
Trimethadione—Decreased appetite—Methotrexate—psoriasis	0.000147	0.000609	CcSEcCtD
Trimethadione—Rash—Betamethasone—psoriasis	0.000146	0.000607	CcSEcCtD
Trimethadione—Rash—Dexamethasone—psoriasis	0.000146	0.000607	CcSEcCtD
Trimethadione—Dermatitis—Betamethasone—psoriasis	0.000146	0.000606	CcSEcCtD
Trimethadione—Dermatitis—Dexamethasone—psoriasis	0.000146	0.000606	CcSEcCtD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000146	0.00857	CbGpPWpGaD
Trimethadione—Fatigue—Methotrexate—psoriasis	0.000146	0.000604	CcSEcCtD
Trimethadione—Headache—Betamethasone—psoriasis	0.000145	0.000603	CcSEcCtD
Trimethadione—Headache—Dexamethasone—psoriasis	0.000145	0.000603	CcSEcCtD
Trimethadione—Asthenia—Prednisone—psoriasis	0.000145	0.000601	CcSEcCtD
Trimethadione—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000144	0.00848	CbGpPWpGaD
Trimethadione—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000144	0.00847	CbGpPWpGaD
Trimethadione—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000144	0.00845	CbGpPWpGaD
Trimethadione—Pruritus—Prednisone—psoriasis	0.000143	0.000593	CcSEcCtD
Trimethadione—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000142	0.00836	CbGpPWpGaD
Trimethadione—Feeling abnormal—Methotrexate—psoriasis	0.000139	0.000577	CcSEcCtD
Trimethadione—Gastrointestinal pain—Methotrexate—psoriasis	0.000138	0.000573	CcSEcCtD
Trimethadione—Nausea—Betamethasone—psoriasis	0.000138	0.000572	CcSEcCtD
Trimethadione—Nausea—Dexamethasone—psoriasis	0.000138	0.000572	CcSEcCtD
Trimethadione—CACNA1G—Developmental Biology—CARM1—psoriasis	0.000135	0.00792	CbGpPWpGaD
Trimethadione—Abdominal pain—Methotrexate—psoriasis	0.000133	0.000554	CcSEcCtD
Trimethadione—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000129	0.00757	CbGpPWpGaD
Trimethadione—Vomiting—Prednisone—psoriasis	0.000128	0.000533	CcSEcCtD
Trimethadione—Rash—Prednisone—psoriasis	0.000127	0.000528	CcSEcCtD
Trimethadione—Dermatitis—Prednisone—psoriasis	0.000127	0.000528	CcSEcCtD
Trimethadione—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000127	0.00747	CbGpPWpGaD
Trimethadione—Headache—Prednisone—psoriasis	0.000127	0.000525	CcSEcCtD
Trimethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000125	0.00736	CbGpPWpGaD
Trimethadione—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000125	0.00734	CbGpPWpGaD
Trimethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000124	0.0073	CbGpPWpGaD
Trimethadione—Asthenia—Methotrexate—psoriasis	0.000121	0.000503	CcSEcCtD
Trimethadione—Nausea—Prednisone—psoriasis	0.00012	0.000498	CcSEcCtD
Trimethadione—Pruritus—Methotrexate—psoriasis	0.000119	0.000496	CcSEcCtD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000118	0.00691	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000117	0.0069	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000116	0.00681	CbGpPWpGaD
Trimethadione—Vomiting—Methotrexate—psoriasis	0.000107	0.000445	CcSEcCtD
Trimethadione—Rash—Methotrexate—psoriasis	0.000106	0.000442	CcSEcCtD
Trimethadione—Dermatitis—Methotrexate—psoriasis	0.000106	0.000441	CcSEcCtD
Trimethadione—Headache—Methotrexate—psoriasis	0.000106	0.000439	CcSEcCtD
Trimethadione—Nausea—Methotrexate—psoriasis	0.0001	0.000416	CcSEcCtD
Trimethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.73e-05	0.00513	CbGpPWpGaD
Trimethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.26e-05	0.00486	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.75e-05	0.00455	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.64e-05	0.00449	CbGpPWpGaD
Trimethadione—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7.43e-05	0.00436	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—TYK2—psoriasis	6.89e-05	0.00405	CbGpPWpGaD
Trimethadione—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.68e-05	0.00393	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—LEP—psoriasis	6.44e-05	0.00379	CbGpPWpGaD
Trimethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.76e-05	0.00339	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—PPARG—psoriasis	5.61e-05	0.0033	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—TYK2—psoriasis	4.92e-05	0.00289	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—VEGFA—psoriasis	4.87e-05	0.00286	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—NFKB1—psoriasis	3.83e-05	0.00225	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—VEGFA—psoriasis	3.48e-05	0.00204	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—STAT3—psoriasis	3.44e-05	0.00202	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—IL6—psoriasis	3.37e-05	0.00198	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—NDUFA5—psoriasis	3.36e-05	0.00197	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—TNF—psoriasis	2.98e-05	0.00175	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—NDUFA5—psoriasis	2.9e-05	0.00171	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CYP2S1—psoriasis	2.86e-05	0.00168	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.71e-05	0.00159	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—NDUFA5—psoriasis	2.59e-05	0.00152	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CYP2S1—psoriasis	2.47e-05	0.00145	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.42e-05	0.00142	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—IL6—psoriasis	2.41e-05	0.00141	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—NDUFA5—psoriasis	2.36e-05	0.00139	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CYP2S1—psoriasis	2.2e-05	0.00129	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.2e-05	0.00129	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYP2S1—psoriasis	2.01e-05	0.00118	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—NDUFA5—psoriasis	1.56e-05	0.000916	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CARM1—psoriasis	1.39e-05	0.000819	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYP2S1—psoriasis	1.32e-05	0.000778	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.29e-05	0.00076	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CARM1—psoriasis	1.21e-05	0.000708	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.15e-05	0.000678	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.13e-05	0.000662	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CARM1—psoriasis	1.08e-05	0.000632	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.05e-05	0.000619	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.01e-05	0.000591	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CARM1—psoriasis	9.81e-06	0.000576	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.17e-06	0.000539	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CAT—psoriasis	8.58e-06	0.000504	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CAT—psoriasis	7.41e-06	0.000436	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—APOE—psoriasis	6.66e-06	0.000392	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CAT—psoriasis	6.62e-06	0.000389	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CARM1—psoriasis	6.47e-06	0.00038	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CAT—psoriasis	6.03e-06	0.000355	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PPARG—psoriasis	5.8e-06	0.000341	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—APOE—psoriasis	5.76e-06	0.000339	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—APOE—psoriasis	5.14e-06	0.000302	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PPARG—psoriasis	5.02e-06	0.000295	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—APOE—psoriasis	4.69e-06	0.000275	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PPARG—psoriasis	4.48e-06	0.000263	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PPARG—psoriasis	4.08e-06	0.00024	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CAT—psoriasis	3.98e-06	0.000234	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—APOE—psoriasis	3.09e-06	0.000182	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PPARG—psoriasis	2.69e-06	0.000158	CbGpPWpGaD
